Summer Sale
50% off Premium Yearly
NASDAQ:CRMD
CorMedix Inc. (CRMD)
Financials 
Technical Analysis 
Jun 11, 2026, 12:00 amThis summary was created by AI, based on 2 opinions in the last 12 months.
CorMedix Inc. (CRMD-Q) has faced a challenging performance recently, with a significant downturn of 25.7%. However, the company is starting to gain traction with its innovative antimicrobial catheter lock, which has demonstrated a substantial reduction in infections, making it a compelling cost-saving solution for healthcare plans. The stock currently trades at 17 times earnings, which is relatively attractive, and has a strong return on equity of 38%. Analysts suggest setting a stop-loss at $9.50 while aiming for a price target of $19.50, indicating a potential upside of 28%. Despite its promising prospects, the recommendation is to remain disciplined by covering the position for the time being due to its recent performance.
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium content
Premium contentCRMD is beginning to see fruit of its antimicrobial catheter lock -- the first and only in the heath space introduced in last year -- that has been clinically proven to reduce infection by over 70% (a BIG cost saver to health plans). It trades at 17x earnings, 4x book and supports a robust 38% ROE. We recommend setting a stop-loss at $9.50, looking to achieve $17.00 -- upside potential of 28%. Yield 0%
(Analysts’ price target is $19.50)- «
- ‹
- 1
- ›
- »
CorMedix Inc. (CRMD) Frequently Asked Questions
What is CorMedix Inc. stock symbol?
CorMedix Inc. is a American stock, trading under the symbol CRMD (previously CRMD-Q on Stockchase) on the NASDAQ (CRMD). It is usually referred to as NASDAQ:CRMD or CRMD
Is CorMedix Inc. a buy or a sell?
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on CRMD (previously CRMD-Q on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for CorMedix Inc..
Is CorMedix Inc. a good investment or a top pick?
CorMedix Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2025-09-04. Read the latest stock experts ratings for CorMedix Inc..
Why is CorMedix Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for CorMedix Inc..
Is CorMedix Inc. worth watching?
CorMedix Inc. is covered by Stockchase experts and is worth watching.
What is CorMedix Inc. stock price?
On 2026-06-12, CorMedix Inc. (CRMD) stock closed at a price of $8.74.
Our PAST TOP PICK with CRMD has triggered its stop at $9.50. To remain disciplined, we recommend covering the position at this time.